Current Report Filing (8-k)
December 08 2016 - 12:39PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 2,
2016
Wound Management Technologies, Inc.
(Exact name of registrant as specified in its charter)
Texas
|
000-11808
|
59-2219994
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
16633 Dallas Parkway, Suite 250
Addison, Texas
|
|
75001
|
(Address
of principal
executive offices)
|
|
(zip
code)
|
Registrant’s telephone number, including area code: (972)
218-0935
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Effective
as of December 2, 2016, Darren Stine resigned from his position as
the Chief Financial Officer of Wound Management Technologies, Inc.
(the “Company”). Effective as of December 8, 2016, the
Company has appointed J. Michael Carmena, 61, to serve as the
Company’s new Chief Financial Officer.
From
2010 until 2013, Mr. Carmena served as Senior Director, Business
& Sales Operations, of Smith and Nephew plc, formerly known as
Healthpoint Therapeutics. Mr. Carmena previously served Healthpoint
Therapeutics as Senior Director, Finance & Administration (from
2008 to 2010) and as Controller (from 1998 to 2008). Prior to his
employment at Healthpoint, Mr. Carmena served as Senior Accounting
Manager, Gulf Coast Business Unit, for Union Pacific Resources
(1997–98); Chief Financial Officer of PNL Asset Management,
L.P. (1995–97); and Manager of Finance, Gulf Coast Business
Unit, for Snyder Oil Corporation (1992–95). Mr. Carmena
started his career at Arthur Andersen & Co. after graduating,
magna cum laude, with a BBA in Accounting from Texas Christian
University in 1978.
The
Board of Directors of the Company believes that Mr. Carmena’s
industry experience will enhance the Company’s sales and
operations teams as well its finance and accounting
functions.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
Wound Management Technologies, Inc.
|
|
|
|
|
|
Date:
December 8, 2016
|
By:
|
/s/
Deborah J. Hutchinson
|
|
|
|
Name:
Deborah J. Hutchinson
|
|
|
|
Title:
President
|
|